Who is sponsoring NCT02959281?

NCT02959281 is sponsored by HaEmek Medical Center, Israel.

What drugs are being tested in NCT02959281?

Interventions in NCT02959281: Providing caring physicians with hemodynamic variables.

What condition does NCT02959281 study?

NCT02959281 studies Cardio-Renal Syndrome.

Is NCT02959281 still recruiting?

NCT02959281 is currently withdrawn. Last updated 28 June 2019.

Last reviewed 2019-06-28 · How we verify

NCT02959281

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bioimpedance and Hand-held Echocardiographay for Clinical Decision-making in Treatment of Cardio-renal Syndrome Type I

Withdrawn NA Last updated 28 June 2019

What this trial tests

NA trial testing Providing caring physicians with hemodynamic variables in Cardio-Renal Syndrome. Withdrawn.

Timeline

1 June 2018

Primary endpoint
16 June 2019

16 June 2019

Quick facts

Lead sponsor	HaEmek Medical Center, Israel
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Start date	1 June 2018
Primary completion	16 June 2019
Estimated completion	16 June 2019

Drugs / interventions tested

Providing caring physicians with hemodynamic variables

Conditions studied

Cardio-Renal Syndrome — all drugs for Cardio-Renal Syndrome →

Sponsor

HaEmek Medical Center, Israel

Who can join

Adults 40 to 90, any sex, with Cardio-Renal Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate whether hemodynamic data obtained by a noninvasive bio-impedance system (NICAS) sampled from patients with cardiorenal syndrome type I (CRS1) improve clinical outcomes. We hypothesize that hemodynamic data provided to the caring physician will improve management of CRS1 patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardio-Renal Syndrome

Currently open trials in the same condition.

NCT07008365 — The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure · Phase 3 · recruiting
NCT06521801 — Cardio-Renal Registry · recruiting
NCT04170855 — Kidney Sodium Content in Cardiorenal Patients · NA · recruiting

Other HaEmek Medical Center, Israel trials

Trials by the same sponsor.

NCT06656286 — Hysteroscopic Intrauterine Suturing · NA · not yet recruiting
NCT06803992 — Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter · Phase 4 · recruiting
NCT06542367 — Trans Canal Tympanoplasty With Local Anesthesia Using Fat Graft and "TachoSil" · NA · not yet recruiting
NCT05732155 — Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury. · Phase 2 · unknown
NCT05933018 — Night Hyperglycemia and Fatty Liver in Type 1 Diabetes · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02959281 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by HaEmek Medical Center, Israel
Last refreshed: 28 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02959281.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing